Capsular contractures following implant-based breast reconstruction in women undergoing risk-reducing mastectomy: national register-based study
Kapselkontrakturen nach implantatbasierter Brustrekonstruktion bei Frauen mit risikoreduzierender Mastektomie: nationale registerbasierte Studie
BJS Open · 01.07.2025 · 9 (4)
DOI: 10.1093/bjsopen/zraf080 ↗Auf einen Blick
Bei 656 Frauen mit 1095 implantatbasierten Rekonstruktionen trat eine schwere Kapselkontraktur bei 3,6 % der Brüste auf. Das Risiko unterschied sich je nach Implantattyp.
Fragestellung
Wie hoch ist die Inzidenz schwerer Kapselkontrakturen nach risikoreduzierender Mastektomie mit implantatbasierter Brustrekonstruktion, und welche Risikofaktoren bestehen?
Methode
Registerbasierte Studie mit Daten aus dem Swedish Breast Implant Register und dem National Patient Register von 2014 bis 2021.
Ergebnisse
39 von 1095 Brüsten (3,6 %) entwickelten eine Kapselkontraktur. Kumulative Inzidenz: 1,9 % nach 1 Jahr und 4,7 % nach 5 Jahren. Permanent tissue expander vs. fixed-volume implant: adjustiertes HR 19,33 (95 %-KI 3,92–95,43; P < 0,001).
Schlussfolgerung der Autor:innen
Das Risiko schwerer Kapselkontrakturen mit Operationsbedarf scheint sich zwischen Implantattypen zu unterscheiden. Die zunehmende Inzidenz über 5 Jahre unterstreicht die Bedeutung der Langzeitnachsorge.
Kernaussagen
- Schwere Kapselkontraktur: 3,6 %
- Kumulative Inzidenz stieg bis 5 Jahre auf 4,7 %
- Höheres Risiko bei permanentem tissue expander als bei fixed-volume implant
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift BJS Open, online erschienen am 29.07.2025. Verfasst von Signe Hägglund und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Plastic Surgery and Surgery, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Breast Implants, Implant Capsular Contracture, Breast Implantation, Breast Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Umeå University, Västerbotten County Council.
Themen: Kontrakturprophylaxe
Abstract (Originalsprache)
Background
The majority of women undergoing risk-reducing mastectomy have implant-based breast reconstruction, with capsular contracture being one of the most common complications. The primary aim of this study was to establish the national incidence rate of severe capsular contracture requiring surgery following risk-reducing mastectomy with implant-based breast reconstruction. The secondary aim was to establish the incidence rate of other complications and associated risk factors.
Methods
Women undergoing implant-based breast reconstruction following risk-reducing mastectomy were identified from the Swedish Breast Implant Register. Data were extracted from the Swedish Breast Implant Register and the National Patient Register on women undergoing implant-based breast reconstruction from 2014 to 2021. The primary outcome was severe capsular contracture corresponding to Baker grade III–IV requiring surgery, and the secondary outcomes were other complications observed perioperatively.
Results
In total, 656 women with 1095 implant-based breast reconstructions were included in the analysis. Median follow-up was 3.5 (interquartile range 1.5–5.4) years. Capsular contracture was observed in 39 of 1095 breasts (3.6%), and the cumulative incidence increased from 1.9% at 1 year to 4.7% after 5 years. Stratified by implant type, the estimated risk of capsular contracture increased for patients with a permanent tissue expander compared with a permanent fixed-volume implant (adjusted hazard ratio 19.33, 95% confidence interval 3.92 to 95.43; P < 0.001).
Conclusion
This study has highlighted that the risk of developing severe capsular contracture requiring surgery seems to differ between implant types, emphasizing the need for further investigation regarding permanent tissue expanders. Moreover, the continuous increase in capsular contracture incidence rates over 5 years underscores the importance of long-term follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Diagnostics and Intervention, Plastic Surgery and Surgery, Umeå University, Umeå, Sweden.
- Department of Statistics, Umeå School of Business, Economics and Statistics, Umeå University, Umeå, Sweden.
- Department of Plastic Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Plastic and Reconstructive Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Department of Reconstructive Plastic Surgery, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Signe Hägglund, Emma Hansson
Förderung
- Umeå University
- Västerbotten County Council
Zitieren
APA
Hägglund, S., Svensson, J., Hansson, E., Halle, M., & Wiberg, R. (2025). Capsular contractures following implant-based breast reconstruction in women undergoing risk-reducing mastectomy: national register-based study. BJS Open, 9(4). https://doi.org/10.1093/bjsopen/zraf080
Vancouver
Hägglund S, Svensson J, Hansson E, Halle M, Wiberg R. Capsular contractures following implant-based breast reconstruction in women undergoing risk-reducing mastectomy: national register-based study. BJS Open. 2025;9(4). doi:10.1093/bjsopen/zraf080
BibTeX
@article{Hgglund2025,
author = {Hägglund, Signe and Svensson, Johan and Hansson, Emma and Halle, Martin and Wiberg, Rebecca},
title = {Capsular contractures following implant-based breast reconstruction in women undergoing risk-reducing mastectomy: national register-based study},
journal = {BJS Open},
year = {2025},
volume = {9},
number = {4},
doi = {10.1093/bjsopen/zraf080}
}
EUVIMED